Inventor · disambiguated record
Yan Zhu
Also filed as: ZHU YAN · Zhu yan-dong
39 granted patents·16 pending applications·405 citations·filing 1999–2022
98Inventor score
Files withMETABOLEX INC10CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD6THERAVANCE INC6CHEN XIN4GENENTECH INC4
Top patents by PatentIndex Score
55 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0293US7432394B2Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2006·Granted Oct 7, 2008·12 cites·21 claims
- 0393US6444786B1Glycopeptide derivatives and pharmaceutical compositions containing the sameADVANCED MEDICINE INC·Filed 2000·Granted Sep 3, 2002·41 cites·32 claims
- 0492US10106661B2Composite material with thermoplastic toughened novolac-based epoxy resin matrixHEXCEL CORP·Filed 2017·Granted Oct 23, 2018·4 cites·12 claims
- 0592US9725439B2Quinazoline derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Aug 8, 2017·13 cites·16 claims
- 0692US6620781B2Glycopeptide carboxy-saccharide derivativesTHERAVANCE INC·Filed 2001·Granted Sep 16, 2003·27 cites·26 claims
- 0792US6455669B1Glycopeptide derivatives and pharmaceutical compositions containing the sameTHERAVANCE INC·Filed 2000·Granted Sep 24, 2002·34 cites·29 claims
- 0892US6392012B1Glycopeptide derivatives and pharmaceutical compositions containing the sameADVANCED MEDICINE INC·Filed 1999·Granted May 21, 2002·70 cites·36 claims
- 0991US8227495B22,4-disubsituted thiazoles and pharmaceutical compositions thereofCHEN XIN·Filed 2009·Granted Jul 24, 2012·13 cites·18 claims
- 1090US8360569B2Phosphate-containing surfactants for use with pigment—and latex-containing ink-jet inksHEWLETT PACKARD DEVELOPMENT CO·Filed 2007·Granted Jan 29, 2013·10 cites·27 claims
- 1190US7714131B2Process for the stereoselective preparation of (−)-halofenate and derivatives thereofMETABOLEX INC·Filed 2006·Granted May 11, 2010·9 cites·16 claims
- 1289US8288384B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2009·Granted Oct 16, 2012·9 cites·1 claims
- 1389US6472393B1Serine protease inhibitorsGENENTECH INC·Filed 2000·Granted Oct 29, 2002·37 cites·19 claims
- 1486US8183381B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2008·Granted May 22, 2012·13 cites·10 claims
- 1586US7265086B2Glycopeptide carboxy-saccharide derivativesTHERAVANCE INC·Filed 2006·Granted Sep 4, 2007·5 cites·13 claims
- 1686US7157554B2Glycopeptide carboxy-saccharide derivativesTHERAVANCE INC·Filed 2005·Granted Jan 2, 2007·8 cites·20 claims
- 1783US6903070B2Glycopeptide carboxy-saccharide derivativesTHERAVANCE INC·Filed 2003·Granted Jun 7, 2005·9 cites·14 claims
- 1882US9550781B2Kinase modulating compounds, compositions containing the same and use thereofCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Jan 24, 2017·9 cites·14 claims
- 1982US7323480B2Substituted triazoles as modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Jan 29, 2008·6 cites·21 claims
- 2081US10376512B1Crystal of aniline pyrimidine compound of trifluoroethyl substituted indole and salt thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Aug 13, 2019·2 cites·14 claims
- 2179US7622491B2Modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Nov 24, 2009·4 cites·57 claims
- 2278US9737537B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·2 claims
- 2378US8481386B2Nanocrystal memories and methods of forming the sameLIU JIANLIN·Filed 2010·Granted Jul 9, 2013·7 cites·9 claims
- 2478US8063021B2Ketolide anti-infective compoundsLI YONG·Filed 2004·Granted Nov 22, 2011·9 cites·20 claims
- 2577US10102941B2Flexible fiber and resin composite core overhead wire and production method thereofFOGANG XINYUAN HENGYE CABLE TECH CO LTD·Filed 2016·Granted Oct 16, 2018·3 cites·7 claims
- 2675US6962970B2Glycopeptide derivatives and pharmaceutical compositions containing the sameTHERAVANCE INC·Filed 2002·Granted Nov 8, 2005·4 cites·10 claims
- 2770US10465052B2Composite material with thermoplastic toughened novolac-based epoxy resin matrixHEXCEL CORP·Filed 2018·Granted Nov 5, 2019·0 cites·20 claims
- 2868US9066870B2Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticlesHU YIQIAO·Filed 2010·Granted Jun 30, 2015·3 cites·25 claims
- 2967US9925189B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·2 claims
- 3064US8921350B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·0 cites·4 claims
- 3161US8975258B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2012·Granted Mar 10, 2015·0 cites·22 claims
- 3259US2010087468A1Modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2009·Application pending·0 cites
- 3358US2007037813A1Serine Protease InhibitorsGENENTECH INC·Filed 2006·Application pending·0 cites
- 3458US2009093650A1Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3556US2015239881A1Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2015·Application pending·0 cites
- 3655US10329277B2N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activityCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jun 25, 2019·0 cites·7 claims
- 3754US2008108630A1Substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2007·Application pending·0 cites
- 3854US2005186198A1Serine protease inhibitorsGENENTECH INC·Filed 2005·Application pending·0 cites
- 3953US2025026750A1Sulfoximine-containing atr inhibitor compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 4052US6919369B2Serine protease inhibitorsGENENTECH INC·Filed 2002·Granted Jul 19, 2005·0 cites·17 claims
- 4147US8846675B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2012·Granted Sep 30, 2014·0 cites·22 claims
- 4246US11485833B2Thermoplastic toughened matrix resins containing nanoparticlesHEXCEL CORP·Filed 2019·Granted Nov 1, 2022·0 cites·14 claims
- 4343US9458170B2Compound of camptothecin and preparation and use thereofLI YULIANG·Filed 2013·Granted Oct 4, 2016·0 cites·4 claims
- 4441US12030880B2Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jul 9, 2024·0 cites·18 claims
- 4541US9242938B2Glycine reuptake inhibitor and use thereofBEIJING MEDISAN TECHNOLOGY CO LTD·Filed 2012·Granted Jan 26, 2016·0 cites·13 claims
- 4641US2011142523A1Key top member for push bottom swithc structureHON HAI PREC IND CO LTD·Filed 2010·Application pending·0 cites
- 4741US2006014785A1Bicyclic, substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2005·Application pending·0 cites
- 4840US2011100791A1Key module and method of making the sameHON HAI PREC IND CO LTD·Filed 2010·Application pending·0 cites
- 4939US2011107868A1Key module with multi-color marksHON HAI PREC IND CO LTD·Filed 2010·Application pending·0 cites
- 5036US2018346418A1Kinase activity regulating compound intermediates preparation methodCENTAURUS BIOPHARMA CO LTD·Filed 2016·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yan Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →